Veozah vs Orilissa
A side-by-side look at two women's health medications advertised on TV. Informational only — not medical advice.
Maintained by TVPills Editorial Team · Site updated November 4, 2026 (not a product-label review)
| Attribute | US Veozah | US Orilissa |
|---|---|---|
| Generic name | fezolinetant Unverified catalogue summary (Generic name) for Veozah in US; not checked against current local product information. | elagolix Unverified catalogue summary (Generic name) for Orilissa in US; not checked against current local product information. |
| Drug class | See official local label Unverified catalogue summary (Drug class) for Veozah in US; not checked against current local product information. | See official local label Unverified catalogue summary (Drug class) for Orilissa in US; not checked against current local product information. |
| Treats | Menopausal hot flashes Unverified catalogue summary (Treats) for Veozah in US; not checked against current local product information. | Endometriosis pain Unverified catalogue summary (Treats) for Orilissa in US; not checked against current local product information. |
| Category | Women's Health Unverified catalogue summary (Category) for Veozah in US; not checked against current local product information. | Women's Health Unverified catalogue summary (Category) for Orilissa in US; not checked against current local product information. |
| Manufacturer | Astellas Pharma US, Inc. (US distributor) Unverified catalogue summary (Manufacturer) for Veozah in US; not checked against current local product information. | AbbVie Unverified catalogue summary (Manufacturer) for Orilissa in US; not checked against current local product information. |
| Year approved | — Unverified catalogue summary (Year approved) for Veozah in US; not checked against current local product information. | — Unverified catalogue summary (Year approved) for Orilissa in US; not checked against current local product information. |
| Catalogue warning level | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Veozah in US; not checked against current local product information. | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Orilissa in US; not checked against current local product information. |
| Est. TV ad spend | $110M | $60M |
| Side effects and serious risks | — Unverified catalogue summary (Side effects and serious risks) for Veozah in US; not checked against current local product information. | — Unverified catalogue summary (Side effects and serious risks) for Orilissa in US; not checked against current local product information. |
Sources and editorial standards
Use the current DailyMed labels to verify approved uses, boxed warnings, and side effects for each medication. Label results can differ by product, strength, and formulation.
Page updated November 4, 2026; the linked resources have not necessarily been reviewed on this date.
Frequently asked questions
Is Veozah or Orilissa better?
This directory does not compare clinical effectiveness or safety. Listing Veozah and Orilissa together does not establish shared approved indications, equivalence or suitability as substitutes. Consult the correct local labels and your prescriber.
What's the difference between Veozah and Orilissa?
The table shows catalogue identification and estimated advertising information for Veozah and Orilissa, not a verified medical comparison. Medical descriptions, mechanisms and safety summaries are withheld.
Which one spends more on TV ads?
Veozah has the larger estimated TV advertising budget of the two.